MEDESIS PHARMA - U.S. PATENT PROTECTION REGISTRATION OF THE FUTURE DRUG ALLOWING THE DECORPORATION OF CESIUM
Subscribe

24 Mar 2022 17:47 CET

Company Name

MEDESIS PHARMA S.A.

ISN

FR0010844464

Market

Euronext Growth

Symbol

ALMDP

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1060149_MEDESISPHARMA_CP_BrevetDeecorporationCesium_EN.pdf

Source

MEDESIS PHARMA

Provider

Les Echos

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Medesis Pharma SA published this content on 24 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 March 2022 17:01:06 UTC.